Mr Alan Whitmore

Chief Scientific Officer at Tangram Therapeutics

Speaker

Alan Whitmore, BM, BCh, PhD, MRCGP, FFPM is the Chief Scientific Officer of Tangram Therapeutics, where he has been instrumental in the conception, design, implementation and development of the ETX computational drug discovery platform and its deployment into GalNAc-siRNA drug discovery and development. He is a clinician-scientist with over 30 years’ experience in cell and computational biology research, drug discovery and clinical medicine and has held a variety of roles including MRC Fellow, UCL Laboratory for Molecular Cell Biology; Visiting Fellow, The Jackson Laboratory, US; and Hon Senior Lecturer, UCL School of Pharmacy, as well as senior clinical management positions.